Tiloram, 125 mg 6 pcs.

Low molecular synthetic interferon inducer that stimulates formation of interferon alpha, beta and gamma in the body. The main producers of interferon in response to tiloron administration are intestinal epithelial cells, hepatocytes, T-lymphocytes, neutrophils and granulocytes. After oral administration the maximum production of interferon is determined in the sequence intestine – liver – blood in 4-24 hours. Tiloron has immunomodulatory and antiviral effects. In human leukocytes it induces synthesis of interferon. It stimulates bone marrow stem cells, and, depending on the dose, increases antibody production, reduces the degree of immunosuppression, restores the ratio of T-suppressors and T-helpers. Effective against various viral infections, including influenza viruses, other acute respiratory viral infections, hepatitis viruses and herpesviruses. The mechanism of antiviral action is associated with inhibition of translation of virus-specific proteins in infected cells, resulting in suppression of virus reproduction.

Pharmacokinetics
After oral administration is quickly absorbed from the gastrointestinal tract. Bioavailability -60%. About 80% of the drug is bound to plasma proteins. The drug is excreted practically unchanged in intestine (70%) and kidney (9%). Excretion period is 48 hours. The drug is not biotransformed and does not accumulate in the body.

Indications

Active ingredient

Composition

How to take, the dosage

Interaction

Special Instructions

Contraindications

Hypersensitivity to Tyloron and other components of the drug.

With caution
in the complex therapy of infectious-allergic and viral encephalomyelitis the drug is used under the supervision of a physician.

Side effects

Similarities